The Food and Drug Administration (FDA) is announcing the sixth annual scientific workshop co-sponsored by the Agency and the Coalition Against Major Diseases (CAMD) Consortium of the Critical Path Institute (C-Path). The purpose of this public workshop is to initiate constructive discussion among scientists from FDA, the CAMD Consortium, and other interested parties regarding ongoing efforts to develop tools and methods to facilitate drug development for Alzheimer's disease and Parkinson's disease.
Document
Sixth Annual Coalition Against Major Diseases/Food and Drug Administration Scientific Workshop; Public Workshop
The Food and Drug Administration (FDA) is announcing the sixth annual scientific workshop co-sponsored by the Agency and the Coalition Against Major Diseases (CAMD) Consortium o...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 45998
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Sixth Annual Coalition Against Major Diseases/Food and Drug Administration Scientific Workshop; Public Workshop,” thefederalregister.org (August 3, 2015), https://thefederalregister.org/documents/2015-18969/sixth-annual-coalition-against-major-diseases-food-and-drug-administration-scientific-workshop-public-workshop.